ApiSyn: From early-phase research and process development to reliable cGMP manufacturing worldwide.
KEY PRODUCTS
Reset all filters
01 1ApiSyn
Reset all filters
01 1APIXABAN
Reset all filters
01 1India
Reset all filters
01 1Active
Reset all filters
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 42365
Submission : 2025-08-27
Status : Active
Type : II
20
Apisyn Healthcare Private Ltd, based in India, is a pharmaceutical company.
They are recognized for ApiSyn: From early-phase research and process development to reliable cGMP manufacturing worldwide.
One of their notable products is APIXABAN, with a corresponding US DMF Number 42365.
Remarkably, this DMF maintains an Active status since its submission on August 27, 2025, highlighting commitment to regulatory compliance.